Overview
The Beta-Amyloid A4 Protein Precursor (740-770), APP (C31) is an essential peptide for researchers investigating Alzheimer’s disease and related neurological conditions. This 31-amino acid peptide directly corresponds to the C-terminal fragment of the Amyloid Precursor Protein (APP), making it a crucial component in understanding the mechanisms that lead to neuronal death. The generation of C31 through caspase cleavage can play a significant role in apoptosis, highlighting the peptide’s importance in your studies.
Key Features
- Corresponds to the C-terminal fragment of APP
- Involved in apoptosis related to Alzheimer’s disease
- Essential for understanding neuronal death mechanisms
- Available in a 1 mg quantity for your research needs
- High purity and quality for optimal results
Specifications
| Attribute | Details |
|---|---|
| Peptide Sequence | 740-770 (C31) |
| Quantity | 1 mg |
| Category | Peptides |
FAQ
What role does the C31 peptide play in Alzheimer’s research?
The C31 peptide is implicated in the apoptosis process linked to neuronal death in Alzheimer’s disease, making it a valuable tool for researchers studying the disease’s underlying mechanisms.
How should I store the Beta-Amyloid A4 Protein Precursor?
For optimal stability, store the peptide at -20°C. Avoid repeated freeze-thaw cycles to maintain its integrity.
Can I use this peptide in combination with other assays?
Yes, the C31 peptide can be effectively used alongside various assay kits available at AnaSpec, such as our PKG Substrate or Autocamtide-2to enhance your research outcomes.
Don’t miss out on this critical peptide for your research into Alzheimer’s disease. Order the Beta-Amyloid A4 Protein Precursor today and add it to your peptide collection. For related products, explore our full range of peptides and find what best fits your research needs!




Reviews
There are no reviews yet.